Countable Labs Launches Category-defining, Highly Sensitive PCR Platform — Countable PCR — Finally Quantifying Rare Events, Even From Limited Samples

Audio By Carbonatix

PALO ALTO, Calif.--(BUSINESS WIRE)--May 13, 2025--

Countable Labs (formerly Enumerix) enters the genomics market with the launch of Countable PCR, redefining what’s possible with PCR for rare event detection. By delivering 10 times more sensitivity and 10 times lower CVs than digital PCR, Countable PCR gives scientists the confidence they’ve been looking for when quantifying rare events, even from limited samples.

“Scientists have always been forced to compromise,” says Eleen Shum, founding scientist & VP of Product at Countable Labs. “Quantitative PCR offers speed but sacrifices accuracy. Digital PCR makes strides towards precision but brings complexity with not a lot of cost savings. And, Next Generation Sequencing is powerful but comes with significant overhead. Countable PCR ends that compromise.”

At the heart of Countable PCR’s new technology is the ability to truly isolate single molecules within over 30 million compartments in a 3D gel matrix. From there, detecting and counting up to one million molecules is simple, direct, and precise.

And, to cut time and cost from current workflows, Countable PCR allows scientists to go from experiment idea to results much faster with the introduction of its Universal Multiplexing Kit — a quicker, cost-effective way to develop multiplex assays in three days and not months.

“This isn’t just about quantifying rare events,” says Jocelyn Davé, CEO of Countable Labs. “It’s about removing friction from genomics workflows so applications that were previously too slow, too complex, or too expensive to scale can finally become routine.”

Countable Labs debuts Countable PCR at ASGCT 2025 from May 13 - 17 in New Orleans.

To learn more about Countable PCR, visit countablelabs.com.

About Countable Labs

Countable Labs is redefining PCR with single-molecule precision and category-defining sensitivity, overcoming the limitations of legacy technologies. Countable PCR delivers 10 times the sensitivity and precision of digital PCR in a single reaction. Plus, it speeds up assay development with simplified multiplexing. These breakthroughs unlock high-sensitivity applications that were previously impractical due to cost and complexity.

View source version on businesswire.com:https://www.businesswire.com/news/home/20250513717316/en/

CONTACT: John Valdez, VP of Marketing

[email protected]

650.468.0054

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA LOUISIANA

INDUSTRY KEYWORD: GENERAL HEALTH HEALTH GENETICS SCIENCE RESEARCH

SOURCE: Countable Labs

Copyright Business Wire 2025.

PUB: 05/13/2025 03:54 PM/DISC: 05/13/2025 03:53 PM

http://www.businesswire.com/news/home/20250513717316/en